重症监护中使用血管活性药物患者股动脉-桡动脉压力梯度的无创检测
本研究纳入81例需要血管活性药物并同时置有股动脉和桡动脉测压的重症患者,每小时测量 invasive 桡动脉和股动脉压力及无创肱动脉血压,共228次测量。以平均动脉压差>10 mmHg或收缩压差>25 mmHg定义为有意义的FR-APG,患病率18.5%[95%CI 10.8-28.7%],糖尿病与FR-APG显著相关。采用肱动脉无创MAP与桡动脉MAP差值11 mmHg为阈值检测FR-APG,特异度92%[67;100]、敏感度100%[95%CI 83;100]、AUC ROC 0.93[95%CI 0.81-0.99]。结论提示NIBR-APG评估可用于检测有意义的FR-APG,后者在每5例需要血管活性药物的重症患者中约出现1例。
要点
- 在需要血管活性药物的ICU患者中,有意义的股动脉-桡动脉压力梯度(FR-APG)患病率为18.5%[95%CI 10.8-28.7%],即约每5例中有1例。
- 以肱动脉无创MAP与桡动脉MAP差值11 mmHg为阈值检测FR-APG,敏感度100%[95%CI 83;100]、特异度92%[67;100]、AUC ROC 0.93[95%CI 0.81-0.99]。
- 糖尿病与有意义的FR-APG显著相关。
- 收缩压FR-APG与收缩压NIBR-APG相关(r2=0.36;p<0.001),平均动脉压FR-APG与平均动脉压NIBR-APG相关(r2=0.34;p<0.001)。
- 有意义的FR-APG定义为平均动脉压差>10 mmHg或收缩压差>25 mmHg。
适用人群与场景
- 成人ICU患者,需要血管活性药物,并同时置有股动脉和桡动脉测压管路。
诊断标准与关键阈值
- 有意义的股动脉-桡动脉压力梯度(FR-APG,参考标准)定义为平均动脉压(MAP)差值>10 mmHg或收缩压(SAP)差值>25 mmHg。
- 无创肱动脉-桡动脉压力梯度(NIBR-APG,指标试验)以肱动脉无创MAP与桡动脉MAP差值11 mmHg为阈值检测有意义的FR-APG。
研究设计与关键结果
- 研究类型为诊断准确性研究,纳入81例成人ICU患者,年龄68[IQR 58-75]岁,SAPS2评分35(SD 7),共获得228次测量。
- 有意义的FR-APG发生于15例患者,患病率18.5%[95%CI 10.8-28.7%]。
- 糖尿病与有意义的FR-APG显著相关。
- 以肱动脉无创MAP与桡动脉MAP差值11 mmHg为阈值检测有意义的FR-APG:特异度92%[67;100]、敏感度100%[95%CI 83;100]、AUC ROC 0.93[95%CI 0.81-0.99]。
- 收缩压FR-APG与收缩压NIBR-APG相关(r2=0.36;p<0.001),平均动脉压FR-APG与平均动脉压NIBR-APG相关(r2=0.34;p<0.001)。
证据类型、等级与局限
- 证据类型:诊断准确性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,NIBR-APG评估可用于检测有意义的FR-APG,后者在每5例需要血管活性药物的重症患者中约出现1例。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: In patient requiring vasopressors, the radial artery pressure may underestimate the true central aortic pressure leading to unnecessary interventions. When using a femoral and a radial arterial line, this femoral-to-radial arterial pressure gradient (FR-APG) can be detected. Our main objective was to assess the accuracy of non-invasive blood pressure (NIBP) measures; specifically, measuring the gradient between the NIBP obtained at the brachial artery and the radial artery pressure and calculating the non-invasive brachial-to-radial arterial pressure gradient (NIBR-APG) to detect an FR-APG. The secondary objective was to assess the prevalence of the FR-APG in a targeted sample of critically ill patients.
METHODS: Adult patients in an intensive care unit requiring vasopressors and instrumented with a femoral and a radial artery line were selected. We recorded invasive radial and femoral arterial pressure, and brachial NIBP. Measurements were repeated each hour for 2 h. A significant FR-APG (our reference standard) was defined by either a mean arterial pressure (MAP) difference of more than 10 mmHg or a systolic arterial pressure (SAP) difference of more than 25 mmHg. The diagnostic accuracy of the NIBR-APG (our index test) to detect a significant FR-APG was estimated and the prevalence of an FR-APG was measured and correlated with the NIBR-APG.
RESULTS: Eighty-one patients aged 68 [IQR 58-75] years and an SAPS2 score of 35 (SD 7) were included from which 228 measurements were obtained. A significant FR-APG occurred in 15 patients with a prevalence of 18.5% [95%CI 10.8-28.7%]. Diabetes was significantly associated with a significant FR-APG. The use of a 11 mmHg difference in MAP between the NIBP at the brachial artery and the MAP of the radial artery led to a specificity of 92% [67; 100], a sensitivity of 100% [95%CI 83; 100] and an AUC ROC of 0.93 [95%CI 0.81-0.99] to detect a significant FR-APG. SAP and MAP FR-APG correlated with SAP (r2 = 0.36; p < 0.001) and MAP (r2 = 0.34; p < 0.001) NIBR-APG.
CONCLUSION: NIBR-APG assessment can be used to detect a significant FR-APG which occur in one in every five critically ill patients requiring vasoactive agents.
参考来源
- Jacquet-Lagrèze M, Claveau D, Cousineau J, et al. Non-invasive detection of a femoral-to-radial arterial pressure gradient in intensive care patients with vasoactive agents. J Intensive Care. 2021. PMID: 34838150. doi:10.1186/s40560-021-00585-1
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。